Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Taxes (2016 - 2025)

Historic Change in Taxes for Enanta Pharmaceuticals (ENTA) over the last 12 years, with Q2 2025 value amounting to $31.9 million.

  • Enanta Pharmaceuticals' Change in Taxes rose 743490.57% to $31.9 million in Q2 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year increase of 329547.74%. This contributed to the annual value of $33.8 million for FY2025, which is 329547.74% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Change in Taxes of $31.9 million as of Q2 2025, which was up 743490.57% from $1.4 million recorded in Q1 2025.
  • Enanta Pharmaceuticals' 5-year Change in Taxes high stood at $31.9 million for Q2 2025, and its period low was -$8.5 million during Q4 2021.
  • Its 5-year average for Change in Taxes is $3.1 million, with a median of $360500.0 in 2024.
  • Examining YoY changes over the last 5 years, Enanta Pharmaceuticals' Change in Taxes showed a top increase of 5097000.0% in 2023 and a maximum decrease of 1418500.0% in 2023.
  • Enanta Pharmaceuticals' Change in Taxes (Quarter) stood at -$8.5 million in 2021, then soared by 99.82% to -$15000.0 in 2022, then soared by 4966.67% to $730000.0 in 2023, then tumbled by 39.04% to $445000.0 in 2024, then surged by 7079.33% to $31.9 million in 2025.
  • Its last three reported values are $31.9 million in Q2 2025, $1.4 million for Q1 2025, and $445000.0 during Q4 2024.